STOCK TITAN

TransMedics to Participate in Upcoming Virtual Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

TransMedics Group, Inc. (NASDAQ: TMDX) announced its participation in two virtual investor conferences. The management team will attend the Oppenheimer Fall MedTech Summit on November 12, 2020, and the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020. These events will consist of 1x1 meetings only, with no webcasts available. TransMedics is a leader in portable extracorporeal warm perfusion for organ transplantation, focusing on enhancing organ quality and viability for patients with end-stage organ failure.

Positive
  • None.
Negative
  • None.

ANDOVER, Mass., Oct. 29, 2020 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (NASDAQ: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today that members of the management team will be virtually participating in two upcoming investor conferences. TransMedics will participate in the Oppenheimer Fall MedTech Summit on November 12, 2020, followed by the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020.

Event: Oppenheimer Fall MedTech Summit
Format: 1x1 Meetings
Date: Thursday, November 12, 2020

Event: Canaccord Genuity Virtual MedTech & Diagnostics Forum
Format: 1X1 Meetings
Date: Thursday, November 19, 2020

As management will be participating in 1x1 meeting only, no webcasts will be available.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/transmedics-to-participate-in-upcoming-virtual-investor-conferences-301163404.html

SOURCE TransMedics Group, Inc.

FAQ

What are the dates for TransMedics' investor conferences?

TransMedics will participate in the Oppenheimer Fall MedTech Summit on November 12, 2020, and the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020.

What is the format of the upcoming events for TransMedics?

The upcoming events will feature 1x1 meetings only, with no webcasts available.

What does TransMedics specialize in?

TransMedics specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation.

What is the stock symbol for TransMedics?

The stock symbol for TransMedics is TMDX.

Where is TransMedics Group, Inc. headquartered?

TransMedics Group, Inc. is headquartered in Andover, Massachusetts.

TransMedics Group, Inc.

NASDAQ:TMDX

TMDX Rankings

TMDX Latest News

TMDX Stock Data

2.52B
32.48M
3.18%
111.8%
25.11%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ANDOVER